PTC Therapeutics Inc.

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

230 new people
337 new organizations
276 new photos
878 job history records for people in our database
512 education records for people in our database
1188 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
9 new people through the revolving door
176 new policy reports
57 new trips to our privately funded travel database
155 new personal financial disclosures
11424 new press releases
11 new town halls
56 new hearings

Caught Our Eye Rss

Former Hill intern returns as press secretary

by Heavyn Lester on 05/08/2024
Natural resources is a trending lobbying topic

by Heavyn Lester on 05/06/2024
LA leaves Capitol Hill for HillEast

by Heavyn Lester on 05/03/2024
Alignment Government Strategies expands partner list

by Heavyn Lester on 05/01/2024
T-Mobile rings House Ethics Committee counsel

by Heavyn Lester on 04/30/2024

» More from Caught Our Eye

Follow @LegiStorm

LegiStorm adds Q4 salary analytics and turnover data

2024-03-14
LegiStorm adds House Q4 salaries and expenses

2024-03-08
LegiStorm publishes longform member biographies

2024-02-01
LegiStorm adds latest Senate salary data

2023-12-19

» More from our DevBlog

Viral post misrepresents McConnell's net worth, falsely links to insider trading | Fact check

by USA Today on 04/18/2024
Exclusive — Mike Johnson’s Top Policy Adviser Is Former Lobbyist: Clients Have Corporate Interest in Ukraine War

by DNYUZ on 04/17/2024
This senator wants an online privacy law. She’s slowed efforts for years.

by The Washington Post on 04/13/2024
Marjorie Taylor Greene won’t say what happened to her Trump Media stock

by CNBC on 04/12/2024

Information

Website: https://www.ptcbio.com

Organization's Own Description:

PTC Therapeutics, Inc. (PTC) is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled proprietary technologies and extensive knowledge of post-transcriptional control processes that it applies in its drug discovery and development activities. PTC's current pipeline of clinical and preclinical product candidates addresses multiple indications, including genetic disorders, oncology, and infectious diseases.

General Contact Information:

Wikipedia

Bloomberg Business profile

Address:

View Larger Map

Subscribers to LegiStorm Pro see the full address information for PTC Therapeutics Inc.. Click here to see more LegiStorm Pro benefits and subscribe, or log in to your Pro account.

Earmarks

PTC Therapeutics Inc. is the recipient of earmarks in the federal government budget. In this section, LegiStorm Pro users can see summaries of those earmarks. Click here to see more LegiStorm Pro benefits and subscribe, or log in to your Pro account.

Lobbying and Foreign Representation

PTC Therapeutics Inc. has lobbied the U.S. government. LegiStorm Pro users can see summaries of that lobbying activity. Click here to see more LegiStorm Pro benefits and subscribe, or log in to your Pro account.

Related Entities

Employees

Subscribers to LegiStorm Pro see those people in our database known to work for PTC Therapeutics Inc.. Click here to see more LegiStorm Pro benefits and subscribe, or log in to your Pro account.

Weekly Updates

Caught Our Eye Rss

Social Media

DevBlog Rss

In the News